JavaScript required for full functionality. Enable JavaScript to use the interactive analysis tools.
Health panel approves coverage for iPS cell-derived Parkinson’s disease treatment
- Publication
- The Japan Times
- Author
- Jessica Speed
- Published
- May 13, 2026
- BS Rank
- 21.5% percentile (5,631 of 7,171)
- BS Score
- 39.54%
- Analysis source
- gemini
Health panel approves coverage for iPS cell-derived Parkinson’s disease treatment - gemini analysis on antibsmachine.
Top detected reasoning patterns
- Unattributed Quote: 50%
- Halo Effect: 39.8%
- Primacy Effect: 39.8%
- Appeal to Authority: 39.8%
- Indoctrination: 39.8%
- Framing Effect: 31.6%
Topics
Parkinsons Disease, Ips Cells, Healthcare
Keywords
Mhlw, Medicine, Parkinsons Disease, Sumitomo Pharma, Ips, Pharmaceuticals, National Health Care, Stem Cells